Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In ...
No.685360 LY3857210慢性腰痛の治… - ラクオリア創薬(株)【4579】の掲示板 2022/11/26〜2022/12/04 ...
No.685923 イーライリリーに導出されたP2… - ラクオリア創薬(株)【4579】の掲示板 2022/12/05〜2022/12/14 ...
The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of ...
Eli Lilly sidelines pain prospect in another pipeline shift
LY3437943 | CAS#:2381089-83-2 | Chemsrc
Lilly Refines Pain Pipeline Again, Scrapping Mid-Stage Program - BioSpace
LY345899 ≥95% (HPLC) | Sigma-Aldrich
Diabetic Neuropathy Treatment Market Size Report, 2030
Chemical structures of references products BAY11-7082 and LY3200882 ...
LY2880070 | Chk inhibitor | CAS 1375637-35-6 | Selleck
Methods | Small Molecule Biomarker Core
Ly3502970 | 2212020-52-3
LY2365109 | GlyT1 Inhibitor | MedChemExpress
LY25648 | MedChemExpress
36951-72-1 - Luminescence technology corp.
LY 189332 | Antimetastatic Agent | MedChemExpress
Eli Lilly to Expand Pain Pipeline With $1B SiteOne Buyout Offer - May ...
Synthesis of the LY294002 derivative and evaluation of binding to class ...
LY255283 | LTR antagonist | CAS 117690-79-6 | Selleck
LY 806303 | Thrombin Inhibitor | MedChemExpress
244263-49-8 - Luminescence technology corp.
Chemical structure of LY404039. For comparison, the chemical structure ...
千亿镇痛市场，天亮了
New drug candidates shine in San Diego
Structure of LY294002 | Download Scientific Diagram
Crystallographic data | Download Table
LY294002 | Cell Signaling Technology
Eli Lilly’s $1 Billion Bet On SiteOne: Can Non-Opioid Pain Drugs ...
ML385 | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
The structures of LY173013 and LY186826. | Download Scientific Diagram
Areas of Interest | Partnering | Asahi Kasei Therapeutics Corporation
Lilly adds to non-opioid pain pipeline with Confo deal | pharmaphorum
Ibuprofen + dexamethasone + educational intervention for Radiating Back ...
Global Diabetic Neuropathy Treatment (Peripheral,
ALXN2050 for Impaired Hepatic Function Clinical Trial 2022 | Power
Chemical structure and relevant properties of LY3009120 (Wesley, 2017 ...
Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl ...
LY3009120 |CAS:1454682-72-4 Probechem Biochemicals
103852-92-6 - Luminescence technology corp.
Z2206320703 | IspC Lead Candidate Compound | MedChemExpress
LY280748 | MedChemExpress
LY3154207 | D1 Receptor PAM | MedChemExpress
LY326325 | MedChemExpress
LY 171883, 98% 10 mg | Contact Us | Thermo Scientific Chemicals ...
LY364947 | STEMCELL Technologies
LY 106737 | C21H27NO | CID 134131 - PubChem
LY 171883 | CAS 88107-10-2 | SCBT - Santa Cruz Biotechnology
LY 2365109 hydrochloride | Cas# 868265-28-5 - GlpBio
LY-3475070 | CD markers inhibitor | CAS 2375815-63-5 | Selleck
LY-3537982|CAS 2414198-64-2|DC Chemicals
LY3556050 | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
LY 311727 - Selective Factor Xa Inhibitor | APExBIO
LY2510924
LY3009120 | CAS 1454682-72-4 | SCBT - Santa Cruz Biotechnology
LY137150 | MedChemExpress
LY300503 | LY191704 Enantiomer | MedChemExpress
ZLY032 | PPAR Agonist | MedChemExpress
1088715-84-7 | LY2510924 | ChemScene
1425710-74-2 - Luminescence technology corp.
(±)-LY395756 | mGlu2 Receptor Agonist | MedChemExpress
阿尔茨海默病: 近期美国有没有新药上市？
LY382884 | GluR5 Antagonist | MedChemExpress
LY3437943 | Excenen PharmaTech
56842-95-6 - Luminescence technology corp.
LY-303,511 - Enzo
866927-10-8[IC87201 97%]- Jizhi Biochemical
LY2603618 ≥98% (HPLC) | Sigma-Aldrich
Y16-4F, Y11｜2271032-12-1 - Luminescence technology corp.
Chemical Product Catalog _Letter P_Page 185_Chemicalbook
LY-2090314 | 603288-22-8 | Reference standards | Shimadzu Chemistry ...
1236108-27-2 - Luminescence technology corp.
Structure of LY3023414. | Download Scientific Diagram
LY207702 | Antitumor Compound | MedChemExpress
475102-99-9 - Luminescence technology corp.
LY3372689 | Excenen PharmaTech
LY2784544 (CAS 1229236-86-5) | Glentham Life Sciences
L 858051 | MedChemExpress
The chemical structure of LY2606368. | Download Scientific Diagram
LY-3009120(1454682-72-4) 1H NMR spectrum
LY 2140023 CAS#: 635318-55-7
Chemical structure of LX519290. LX519290 was synthesized using the ...
36852-02-5 - Luminescence technology corp.
LY108742 | 5-HT2 Receptor Antagonist | MedChemExpress
LY 186826 | Antibiotic | MedChemExpress
AM1710 | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
LY3202626
LY 2874455 | 1254473-64-7
LY-411575
Buy Opioid Receptors | Life Sciences - Ligands Products | Biosynth
LY03005
1261889-89-7 - Luminescence technology corp.
CAS Number List_-4_Page107_Chemicalbook
1435710-71-6 - Luminescence technology corp.
LY310762 | 5-HT Receptor Inhibitor | MedChemExpress
LY 215890 | Antibacterial Agent | MedChemExpress
LY2584702 | CAS 1082949-67-4 | AbMole BioScience | LY2584702 Price
B4PYMPM｜1030380-51-8 - Luminescence technology corp.
LY2157299
LY-2874455 - LKT Labs
853722-91-5 - Luminescence technology corp.
FTY720 = 98 HPLC 162359-56-0
LY-411575 209984-57-6 | Tokyo Chemical Industry Co., Ltd.(APAC)
1227780-71-3 - Luminescence technology corp.
528610-01-7 - Luminescence technology corp.
LY2510924 (LY-2510924) | CAS 1088715-84-7 | AbMole BioScience ...
LY 2365109 hydrochloride (LY 2365109 hcl) | CAS 868265-28-5 | AbMole ...
LY 150310 | C13H14N2 | CID 124205 - PubChem
LY 225910 | CAS 133040-77-4 | SCBT - Santa Cruz Biotechnology
2607030-72-6 - Luminescence technology corp.
Chemical structure of LY333328. | Download Scientific Diagram
LY 362884 | Semantic Scholar
YM-155, 781661-94-7 | BroadPharm
CAS Number List_1_Page1141_Chemicalbook
:%0A%0AALXN2050%20for%20Impaired%20Hepatic%20Function.png?md=1)
